Business Development

Collaborations and partnerships are core components of Novakand Pharma’s business model.

The company’s strategy is to develop and commercialize its candidate drugs by partnering with other leading biotech and pharmaceutical companies that are focusing on cardiovascular diseases.

Please contact CEO Peter Selin for any business development enquiries: peter.selin@novakand.com.